The initial success of Sildenafil undeniably revolutionized the medication landscape, but betting in companies heavily reliant on generic versions presents a complex picture. While early returns were significant, the expiration of patents and the appearance of less expensive alternatives have eroded the customer base. Consequently, a thorough asses